Fig. 3
From: BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
Kaplan Meier survival analysis and BRCA2 mRNA-expression in OC patients according the 21st percentile as cut-off value. a Progression-free survival and b overall survival in 168 OC patients. c Progression-free survival and d overall survival in 136 patients with BRCA1-wildtype tumors
